QIAGEN selected by Japan’s National Cancer Center for monogenetic screening and molecular oncology of patients

An announcement was made today by QIAGEN that its QIAGEN Clinical Insight offering was chosen by the Japan’s National Cancer Center, as a part of the program of Ministry of Labor, Health and Welfare’s precision medicine program of Japan, for…